The current valuation score of ARS Pharmaceuticals Inc is 6.63, ranking 276 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.56, which is -7138.83% below the recent high of 180.34 and -4426.57% above the recent low of -115.98.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.